BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18349075)

  • 1. A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-kappaB.
    Stilo R; Varricchio E; Liguoro D; Leonardi A; Vito P
    J Cell Sci; 2008 Apr; 121(Pt 8):1165-71. PubMed ID: 18349075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
    Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
    Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation.
    Marasco D; Stilo R; Sandomenico A; Monti SM; Tizzano B; de Capua A; Varricchio E; Liguoro D; Zotti T; Formisano S; Ruvo M; Vito P
    Biochem J; 2009 Aug; 422(3):553-61. PubMed ID: 19538180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
    Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
    J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.
    McAllister-Lucas LM; Ruland J; Siu K; Jin X; Gu S; Kim DS; Kuffa P; Kohrt D; Mak TW; Nuñez G; Lucas PC
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):139-44. PubMed ID: 17101977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl10 is an essential regulator for A20 gene expression.
    Xu W; Xue L; Sun Y; Henry A; Battle JM; Micault M; Morris SW
    J Physiol Biochem; 2013 Dec; 69(4):821-34. PubMed ID: 23677497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
    Verstrepen L; Carpentier I; Verhelst K; Beyaert R
    Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dishevelled, EGL-10 and pleckstrin (DEP) domain-containing protein DEPDC7 binds to CARMA2 and CARMA3 proteins, and regulates NF-κB activation.
    D'Andrea EL; Ferravante A; Scudiero I; Zotti T; Reale C; Pizzulo M; De La Motte LR; De Maio C; Mazzone P; Telesio G; Vito P; Stilo R
    PLoS One; 2014; 9(12):e116062. PubMed ID: 25541973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-translational modifications regulate distinct functions of CARMA1 and BCL10.
    Thome M; Weil R
    Trends Immunol; 2007 Jun; 28(6):281-8. PubMed ID: 17468049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex.
    Rehman AO; Wang CY
    Int J Oral Sci; 2009 Sep; 1(3):105-18. PubMed ID: 20695076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of calmodulin with Bcl10 modulates NF-kappaB activation.
    Edin S; Oruganti SR; Grundström C; Grundström T
    Mol Immunol; 2010 Jul; 47(11-12):2057-64. PubMed ID: 20439115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inhibitory effect of A20 on NF-kappaB activation in airway epithelium upon influenza virus infection.
    Onose A; Hashimoto S; Hayashi S; Maruoka S; Kumasawa F; Mizumura K; Jibiki I; Matsumoto K; Gon Y; Kobayashi T; Takahashi N; Shibata Y; Abiko Y; Shibata T; Shimizu K; Horie T
    Eur J Pharmacol; 2006 Jul; 541(3):198-204. PubMed ID: 16765340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
    Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
    Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
    Wegener E; Krappmann D
    Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A20 inhibits NF-kappa B activation downstream of multiple Map3 kinases and interacts with the I kappa B signalosome.
    Zetoune FS; Murthy AR; Shao Z; Hlaing T; Zeidler MG; Li Y; Vincenz C
    Cytokine; 2001 Sep; 15(6):282-98. PubMed ID: 11594795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A20-mediated negative regulation of canonical NF-κB signaling pathway.
    Pujari R; Hunte R; Khan WN; Shembade N
    Immunol Res; 2013 Dec; 57(1-3):166-71. PubMed ID: 24242761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CARMA3: Scaffold Protein Involved in NF-κB Signaling.
    Zhang S; Lin X
    Front Immunol; 2019; 10():176. PubMed ID: 30814996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors.
    Wang D; You Y; Lin PC; Xue L; Morris SW; Zeng H; Wen R; Lin X
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):145-50. PubMed ID: 17179215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling.
    Shembade N; Parvatiyar K; Harhaj NS; Harhaj EW
    EMBO J; 2009 Mar; 28(5):513-22. PubMed ID: 19131965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter.
    Wang YY; Li L; Han KJ; Zhai Z; Shu HB
    FEBS Lett; 2004 Oct; 576(1-2):86-90. PubMed ID: 15474016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.